Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
上 海 復 星 醫 藥( 集 團 )股 份 有 限 公 司
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.*
(a joint stock limited company incorporated in the People's Republic of China with limited liability)
(Stock Code: 02196)
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTION
The board of directors (the ''Board'') of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.* currently comprises 11 directors. Their names, roles and function are set out below:
Executive directors:
Mr. CHEN Qiyu (chairman)
Mr. YAO Fang (co-chairman)
Mr. WU Yifang
Non-executive directors:
Mr. XU Xiaoliang
Mr. GONG Ping
Mr. PAN Donghui
Mr. ZHANG Houlin
Independent non-executive directors:
Mr. JIANG Xian
Dr. WONG Tin Yau Kelvin
Ms. LI Ling
Mr. TANG Guliang
- 1 -
There are five Board committees. The table below provides membership information of these committees, on which each Board member serves.
Environmental, | |||||
Remuneration | Social and | ||||
Strategic | Audit | Nomination | and Appraisal | Governance | |
Committee | Committee | Committee | Committee | Committee | |
Executive directors | |||||
Mr. CHEN Qiyu | C | M | |||
Mr. YAO Fang | M | ||||
Mr. WU Yifang | M | M | |||
Non-executive directors | |||||
Mr. XU Xiaoliang | M | ||||
Mr. GONG Ping | M | ||||
Mr. PAN Donghui | M | M | |||
Mr. ZHANG Houlin | |||||
Independent non-executivedirectors | |||||
Mr. JIANG Xian | M | C | M | ||
Dr. WONG Tin Yau Kelvin | C | C | |||
Ms. LI Ling | M | M | M | ||
Mr. TANG Guliang | C | M |
Notes:
- Chairman of the relevant Board committee M Member of the relevant Board committee
Shanghai, People's Republic of China
9 October 2020
- for identification purposes only
- 2 -
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. published this content on 09 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 October 2020 12:59:08 UTC